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Abstract Occasionally new and intriguing roles arise for 
proteins with well established functions. The alpha-1 serum 
protease inhibitor (a-1 PI) represents another example. Sequence 
identities exist in the a-1 PI and in a nuclear 52-kDa 
glycoprotein which is involved in resistant DNA-polypeptide 
complexes. The results of Western blots support the identity of 
the two proteins and inununocytochemical studies indicate the 
nuclear location of the a-1 PI. Consistently, e.g. Ehrlich ascites 
tumor cells express the a-1 PI, and the fusion protein between 
the a-1 PI and the green fluorescent protein from Aequorea 
victoria shows intracellular accumulation and partly nuclear 
location. 
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1. Introduction 
Human alpha-1 antitrypsin (a-1 AT, swiss: alat_human, 
46.7-kDa polypeptide, glycosylated) is known to be a serum 
protease inhibitor which is secreted by liver cells and which is 
primarily involved in the control of elastolytic activity. Low-
ering of the blood concentration of this protein induces pul-
monary emphysema [1]. The homologous murine protein 
(82% similarities, 65% identities) is expectedly involved in 
the same function and has been termed alpha-1 protease in-
hibitor-! (a-1 PI, swiss: alal_mouse, 46-kDa polypeptide, 
glycosylated). However, these protease inhibitors may have 
additional, e.g. not yet characterized and even more important 
intracellular functions. Previous immunocytochemical studies 
pointed to a potential intracellular accumulation of a-1 AT in 
normal and in tumor cells [2-5]. However, these results were 
not verified by other methods and the significance of this 
potential intracellular location of a-1 protease inhibitors and 
their subcellular distributions have not yet been investigated. 
Studying tight DNA-protein complexes we characterized a 
supramolecular structure consisting of three major glyco-
sylated polypeptides with apparent molecular masses of 
62 kDa, 52 kDa and 40 kDa [6,7]. Complexes of this type 
were found to be attached to DNA isolated from human 
placenta and from murine tumor cells [6]. The DNA-protein 
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complexes survive treatments designed to dissociate DNA-
protein complexes, including cell lysis in the presence of 
SDS and proteinase K, salting out steps, prolonged incuba-
tion in 1% SDS or 4 M urea at 56°C and ethanol precipita-
tions [6,7]. Further characterization of the 52-kDa nuclear 
glycoprotein by partial sequencing and by application of im-
munochemical and recombinant DNA techniques indicates 
that it is identical with the a-1 protease inhibitor which points 
to a nuclear function of this protein. 
2. Materials and methods 
2.1. Preparation of the 52-kDa nuclear protein for microsequencing 
DNA isolation by the 'salting out' procedure and optional modifi-
cations have been described previously in detail [6-8]. Briefly, cell 
pellets of the Ehrlich ascites tumor were suspended in buffer 
(400 mM NaCl, 2 mM EDTA, 10 mM Tris-HCl, pH 8.2) containing 
50 |ig/ml proteinase K. Cell lysis was induced by SDS to obtain a final 
concentration of 0.63°/). The lysates were incubated at 37°C for 18-
25 h. Following dilution, the undigested material was 'salted out' by 
addition of 6 M NaCl. After centrifugation the DNA contained in the 
supernatant was precipitated with ethanol and resuspended in 1 vol of 
Tris/EDTA 0.1 (0.1 mM EDTA, 1 mM Tris-HCl, pH 8.0) containing 
5 ug per ml of DNase I-free pancreatic ribonuclease (ribonuclease I A, 
Pharmacia). Pellets of DNA (1 mg) prepared by ethanol precipitation 
were digested in 50 ul benzonase buffer (1 mM MgCl2, 50 mM Tris-
HCl, pH 8.0) with Benzonase (100 units), mixed with 50 ul of 2 X sam-
ple buffer [9] and submitted to 10% (w/v) SDS-polyacrylamide gel 
electrophoresis [9]. 
2.2. Microsequencing 
The proteins were blotted from gels to PVDF membranes (ProBlot, 
Applied Biosystems) [10] by means of a SemiDry blotting chamber 
(BIO-RAD). Proteins were stained with Ponceau S (Sigma) and re-
gions of interest were cut out and submitted to the microsequencing 
procedure [11]. Sequence analysis was performed on an ABI 477 A 
gas-phase sequencer equipped with on-line 120 PTH analyzer and 
610 A data-acquisition system using standard programs. The FastN 
data base searching program of Lipman and Pearson [12] was used for 
sequence identification in data bases. 
2.3. Antibodies and Western blots 
An antiserum to the 52-kDa nuclear protein has been described 
previously [6]. The antiserum to a-1 AT was a commercial product 
(Paesel). Following SDS-polyacrylamide gel electrophoresis (10%, 
w/v) the polypeptides released from DNA, a-1 AT (Serva), and mo-
lecular weight markers were electro-blotted to nitrocellulose mem-
branes (Schleicher and Schull, BA85). Parallel gel sections were 
stained with Coomassie brilliant blue. After blocking the membranes 
with TTBS (Tris-buffered saline, 0.5% Tween 20) and 5%> dry milk 
they were incubated with the diluted primary antibodies (1:500 v/v, 
TTBS/dry milk) at 4°C, minimum 1 h. After several washes with 
TTBS the immunocomplexes were detected by means of a peroxi-
dase-conjugated secondary antibody and the ECL-detection kit 
(Amersham) which was performed according to the instructions of 
the producer. 
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2.4. Preparation of specimen for immunofluorescence microscopy 
Ehrlich ascites cells settled on poly-prep slides (Sigma) were fixed in 
ethanol (4°C), washed with PBS and incubated with the antiserum to 
human a-1 AT (Paesel, dilution 1: 500, PBS/1% BSA, 60 min at room 
temperature). After several washes with PBS the cells were incubated 
under the same conditions with FITC affinity-pure anti rabbit IgG 
(Jackson, dilution 1: 200, PBS/1% BSA, 60 min at room temperature). 
After washes with PBS, the specimen were incubated with H 33342 
(0.1 |ig/ ml, Sigma). After a final wash in PBS the wet specimen were 
covered with cover slips and directly inspected in the fluorescence 
microscope, and photographed (Kodak Elite, 400). 
2.5. Expression of the alpha-1 protease inhibitor in Ehrlich ascites cells 
Plasmid DNA from an Ehrlich ascites cell RNA-based cDNA li-
brary prepared in the pBluescript vector (Stratagene) was linearized 
by Seal and used as template for PCR amplification of the a-1 PI-
encoding cDNA (Clontech, advantage PCR kit, #kl906-l). Primer 
pairs were used fitting to the coding sequence, e.g. to the first 30 
nucleotides at the 5' end and to 30 bases preceding the stop codon. 
The amplification product was submitted to agarose gel electropho-
resis. 
2.6. Expression constructs and transfection 
The cDNA sequence encoding the enhanced green fluorescent pro-
tein (EGFP, Clontech) was PCR amplified (Clontech, advantage PCR 
kit, #k 1906-1), and the ends were modified during PCR by addition of 
restriction sites: Sail (5' end) and Hindlll (3' end). The product was 
cloned into the Sail/Hindlll sites of the pBluescript KS+ vector (Stra-
tagene) to obtain the plasmid pBlue-EGFP. The authentic coding 
sequence of the murine a-1 PI is comprised in an EST clone (IMAGE 
clone ID 332638) which was kindly supplied to us by the 'Ressour-
cenzentrum im Deutschen Humangenomprojekt', Berlin. Using this 
template the complete coding region for the a-1 PI was PCR ampli-
fied with cDNA-fitting primer pairs and restriction sites were added: 
Kpnl (5' end) and Sail (3' end). Cloning into the pBlue-EGFP (Kpnll 
Sail) resulted in inframe fusion (pBlue-PI-EGFP). The fused sequence 
encoding a-1 PI-EGFP was released (Kpnll'Not!) and recloned in the 
KpnllNotl sites of the eukaryotic expression vector pcDNA3 (Invitro-
gen). For controls the EGFP sequence was recloned in the pcDNA3 
vector using the same restriction sites. Purified plasmids (Qiagen) were 
used to transfect cultured Ehrlich ascites cells (electroporation, Gene 
Pulser II, Biorad, 366 V, 950 uF, 0.8 ml PBS, d = 4 mm). Expression 
was documented by fluorescence microscopy using an FITC filter 
system. 
2.7. Electron microscopy 
DNA associated with the residual complexes was spread by direct 
adsorption to mica (10 mM Tris pH 7.3, 1 mM EDTA, 50 mM 
MgC^) and stained with 1% UCVacetate. Shadowcasting was per-
formed under 5°C by Pt/C = 95/5). Supramolecular structures released 
from DNA by nuclease digestion were visualized by negative staining 
with UO2-acetate. 
3. Results 
Cell lysis in presence of SDS and proteinase K followed by 
'salting out' of residual peptides with saturated sodium chlo-
ride solution resolves efficiently deproteinized DNA [8]. How-
ever, this DNA is still associated with a characteristic set of 
polypeptides (Fig. IC). The residual DNA-polypeptide com-
plexes can be visualized on spread DNA by electron micros-
copy (Fig. 1A). The protein complexes are released during 
digestion of DNA as globular 12 nm particles (Fig. IB) which 
become gradually disassembled resulting in smaller but still 
supramolecular structures [7]. The latter process is accompa-
nied by the activation of an encrypted ATPase/phosphatase 
[7]. Fig. IC shows the characteristic electrophoretic pattern of 
the major polypeptides (62 kDa, 52 kDa and 40 kDa) in-
volved in the SDS and salt-stable DNA-polypeptide com-
plexes. 
Preliminary N-terminal sequence analysis of the 52-kDa 
protein blotted to PVDF membranes showed identities with 
protease inhibitors [6]. By improved methods and by repeated 
assays we now identified reliably 12 amino acid residues which 
are 100% identical with an N-terminal section of the murine 
a-1 PI (Fig. 2). The a-1 PI precursor protein has an N-termi-
nal signal peptide. Consistently, the mature serum protein a-1 
PI starts downstream of this signal peptide with a glutamate 
residue at aa position 25 of the precursor protein (swiss: 
alal_mouse). In contrast, the first residue of the nuclear 
52-kDa protein comprised in the resistant complexes is an 
aspartate residue at aa position 31 of the precursor protein. 
Accordingly, the N-terminal peptide EDVQET of the mature 
serum protein is missing in the 52-kDa nuclear protein. At 
present it is unknown whether this difference reflects an alter-
native post-translational processing of the precursor protein 
or a site-specific cleavage of the nuclear protein during the cell 
lysis in presence of proteinase K. 
The identity between the 52-kDa nuclear protein and the 
a-1 protease inhibitor is further supported by immunochem-
ical cross-reactions. The antibody to the 52-kDa nuclear pro-
tein detects specifically the 52-kDa component among the 
polypeptides released by digestion of DNA isolated by the 
'salting out' procedure ([6] and Fig. 3B). Moreover, it forms 
an immuno complex with human a-1 AT (Fig. 3B). Vice 
versa, the commercially available a-1 AT antiserum shows a 
significant and specific immuno reaction with the 52-kDa 
component of the polypeptides released from DNA (Fig. 
3A). This interspecies cross-reactivity of the two antigens re-
vealed by the two sera further supports the relation of the 
52-kDa nuclear protein and the a-1 PI and the relative inten-
sities of the Western blot signals reflect well the 82% similarity 
between the human and the murine protease inhibitors. 
The DNA-polypeptide complexes shown in Fig. 1 were iso-
lated from Ehrlich ascites cells grown in the peritoneal cavity 
Fig. 1. Release of the nuclear 52-kDa protein from resistant DNA-
associated protein complexes. (A) Electron microscopy of DNA iso-
lated by the 'salting out' procedure [6-8]. Discontinuities are seen 
which reflect non-DNA material. (B) Supramolecular structures re-
leased from DNA after nuclease digestion. (C) SDS polyacrylamide 
gel electrophoresis of polypeptides released from DNA during nucle-
ase digestion. The 52-kDa band marked with an asterisk was sub-
mitted to the microsequencing procedure (see Fig. 2). 
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Fig. 2. Amino terminal peptide sequence of the 52-kDa nuclear 
polypeptide aligned with the peptide sequence of the alpha-1 pro-
tease inhibitor-1 precursor protein (a-1 PI, swiss: alal_mouse). 
of mice. Although these cells were pelleted before cell lysis the 
antigens released from DNA could reflect serum proteins be-
coming associated with the DNA during the isolation proce-
dure. However, such an artificial contamination of the DNA 
with serum a-1 PI is ruled out by the results of immunocy-
tochemical studies. It has been shown previously that the anti-
serum to the 52-kDa polypeptide immuno stains mainly a 
nuclear antigen in whole cells [6]. Fig. 4 shows that the anti-
body to the a-1 AT immuno stains as well mainly the nuclei 
of whole cells which proves the intracellular origin of the 
antigen and eliminates the potential contamination of isolated 
DNA with the serum protein. 
Closely related but non-identical proteins could comprise 
short sequence identities resulting in immunochemical cross-
reactions. Thus, the 52-kDa nuclear protein and a-1 PI could 
still represent very similar but non-identical proteins. How-
ever, by PCR and recombinant DNA technology it can be 
shown that the authentic a-1 PI is expressed in Ehrlich ascites 
cells, and that significant amounts of this protein accumulate 
in cells. The a-1 PI is expressed in Ehrlich ascites cells because 
its coding sequence (1239 Bp) is present in Ehrlich ascites cell 
RNA-based cDNA libraries. This is shown by PCR amplifi-
cation of a ~ 1200 Bp DNA fragment by means of primer 
pairs (each 30 nucleotides) encoding the N-terminal and 
C-terminal sections of the a-1 PI (Fig. 5). 
Moreover, the intracellular accumulation of the a-1 PI can 
be visualized by recombinant DNA technology. The green 
fluorescent protein from the jelly fish Aequorea victoria is a 
reporter molecule suitable for monitoring protein localization 
RB- AT REL AT REL AT M 
a-1 AT serum 52 kDa serum Stained 
Fig. 3. Immunochemical cross-reaction of the (murine) 52-kDa nu-
clear protein and the (human) a-1 AT. An SDS polyacrylamide gel 
(10% w/v) was loaded with the polypeptides released from DNA by 
nuclease digestion (REL), and with commercially available a-1 AT 
(AT). Lane M shows marker proteins. Sections A and B were elec-
troblotted to nitrocellulose. The blot section A was incubated with 
a commercially available antiserum to the human a-1 AT. The blot 
section B was incubated with the antiserum to the 52-kDa nuclear 
protein [6]. After several washes the immuno complexes were de-
tected by the ECL system (Amersham). The gel section C was 
stained with Coomassie brilliant blue. 
and transport in vivo because chimeric proteins consisting of a 
functional protein subunit and the EGFP-tag behave like the 
functional protein [13], e.g. a fusion protein between a secre-
tory protein and the green fluorescent protein does not accu-
mulate in the cell [14]. This system allowed to trace the fate of 
the a-1 PI expressed in Ehrlich ascites cells. Fig. 6 shows that 
Ehrlich ascites cells transfected with the reporter construct 
express the chimeric protein which accumulates inside the 
cells. In agreement with the immunocytochemical studies it 
appears that at least a portion of the protein is transported 
into nuclei where it forms a punctuate fluorescence pattern. 
However, 48 h post transfection a fraction of the a-1 PI still 
resides in the cytoplasm which may reflect either a slow trans-
port of the (overexpressed) protein into nuclei or an addition-
al cytoplasmic function of the protease inhibitor. 
Fig. 4. Intracellular location of the antigen detected by the antise-
rum to a-1 AT. Ehrlich ascites cells were sequentially treated with 
the antiserum to human a-1 AT, FITC-anti-rabbit IgG, and with 
H 33342. (A) Phase contrast microscopy. (B) The same section as 
shown in A, H 33342 fluorescence specific for DNA. (C) The same 
section as shown in A, FITC-fluorescence specific for the antigen 
detected by the a-1 AT antiserum. 
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4. Discussion 
During the last few years the serum oc-1 protease inhibitors 
(human a-1 AT and murine oc-1 PI) met minimal interest 
because these proteins had been well characterized long ago 
on the molecular and functional level [1]. However, well char-
acterized proteins may be utilized in unrelated biological proc-
esses. A prominent example for a multifunctional protein is 
the glycolytic protein glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) which can serve also in other fundamental 
biological processes including DNA repair, translational con-
trol of gene expression, DNA replication and in endocytosis 
[15]. The a-1 protease inhibitor seems to represent another 
example for a protein involved in unrelated functions depend-
ing on its location. 
The electrophoretic mobilities, the glycoprotein nature [1,7], 
the overlapping 12mer microsequence (Fig. 2) and the immu-
nochemical data (Figs. 3 and 4) point to a close similarity 
between a nuclear 52-kDa protein and the a-1 PI. Moreover, 
since the authentic a-1 PI is expressed in Ehrlich ascites cells 
(Fig. 5), and since it accumulates in cells (Fig. 6) our results 
rather reflect the identity of the two proteins than their strong 
similarity. 
Of course, the intrinsic activity of this protein is expectedly 
independent of its location, e.g. it should act inside the cell 
like in the serum as a serine protease inhibitor. This view is 
justified because even the non-glycosylated recombinant a-1 
PI shows inhibition of serine proteases [1]. Accordingly, its 
intracellular fraction is suggestively involved in the regulation 
of pathways governed by serine proteases including serum 
pro tease-mediated apoptosis [16,17]. In such pathways it 
could serve as an antagonist to those serine proteases involved 
in apoptotic death events. Accordingly, the identification of 
the intracellular target protease for the a-1 protease inhibitors 
is of high interest. Possible candidates are those polypeptides 
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Fig. 5. Expression of the a-1 protease inhibitor in Ehrlich ascites 
cells. cDNAs (1239 bp) corresponding to transcripts encoding the 
full length a-1 PI are present in Ehrlich ascites cell RNA-based 
cDNA libraries. A single PCR product (PCR) of the expected size 
is resolved by 1% (w/v) agarose gel electrophoresis after PCR using 
the Seal-linearized plasmid population of the cDNA library as tem-
plate, and primer pairs encoding the N- and C-terminal sections of 
the a-1 PI. 30 cycles, annealing temperature was 60°C. Lane M 
shows DNA marker fragments. 
Fig. 6. Intracellular accumulation of the chimeric protein consisting 
of the authentic a-1 PI and the enhanced green fluorescent reporter 
protein (EGFP). Living Ehrlich ascites cells 48 h post transfection 
with the expression construct encoding a chimeric protein consisting 
of the a-1 PI and the EGFP-tag. The left panels show cells in phase 
contrast. The right panels show the same sections under UV light in 
combination with an FITC filter system. Panel A shows two cells, 
one of which was obviously not transfected with the plasmid. Such 
cells serve as control for negative background fluorescence. The flu-
orescent chimeric protein accumulates in transfected cells. The frac-
tion deposited in nuclei shows a punctuate fluorescence pattern. 
Transfection with the control plasmid encoding only the EGFP re-
sults in a uniform fluorescence in all cellular compartments (not 
shown). 
(62 kDa, 40 kDa) which are found together with the 52-kDa 
nuclear protein in the globular complexes shown in Fig. 1 and 
which are presently characterized on the sequence level. 
Acknowledgements: The authors wish to thank Prof. Dr. Ch. Gran-
zow who supplied the Ehrlich ascites tumor cells and the Ressourcen-
zentrum im Deutschen Humangenomprojekt, Berlin, from which we 
obtained the IMAGE clone 332638. One of us (T.G.) is grateful for a 
fellowship of the German Cancer Research Center, Heidelberg. 
References 
[1] Travis, J. and Salvesen, G.S. (1983) Annu. Rev. Biochem. 52, 
655-709. 
54 
[2] Ordonez, N.G., Manning Jr., J.T. and Hanssen, G. (1983) Am. J. 
Clin. Pathol. 80, 277-282. 
[3] Ordonez, N.G. and Manning Jr., J.T. (1984) Am. J. Gastroenter-
ol. 79, 959-963. 
[4] Tahara, E., Ito, H., Taniyama, K., Yokozaki, H. and Hata, J. 
(1984) Hum. Pathol. 15, 957-964. 
[5] Ordonez, N.G., Manning Jr., J.T. and Mackay, B. (1985) Ultra-
struct. Pathol. 8, 319-331. 
[6] Juodka, B., Spiess, E., Angiolillo, A., Joswig, G., Rothbarth, K. 
and Werner, D. (1995) Nucleic Acids Res. 23, 1359-1366. 
[7] Loeffler, H., Spiess, E., Juodka, B., Stammer, H. and Werner, D. 
(1996) Eur. J. Biochem. 240, 600-608. 
[8] Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) Nucleic 
Acids Res. 16, 1215. 
T. Glaser et al.lFEBS Letters 413 (1997) 50-54 
[9] Laemmli, U.K. (1970) Nature 227, 680-685. 
[10] Kyhse-Andersen, J. (1984) Biophys. Biochem. Meth. 10, 203-
209. 
[11] Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038. 
[12] Lipman, D.J. and Pearson, W.R. (1985) Science 227, 1435-
1441. 
[13] Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. and Prasher, 
D.C. (1994) Science 268, 802-805. 
[14] Kaether, C. and Gerdes, H.H. (1995) FEBS Lett. 369, 267-
271. 
[15] Sirover, M.A. (1996) Life Sci. 58, 2271-2277. 
[16] Shimizu, T. and Pommier, Y. (1996) Exp. Cell Res. 226, 292-301. 
[17] Greidinger, E.L., Miller, D.K., Yamin, T.T., Casciola-Rosen, L. 
and Rosen, A. (1996) FEBS Lett. 390, 299-303. 
